|
|
|
|
Elutia Inc (NASDAQ: ELUT) |
|
|
|
| |
Elutia Inc's Customers Performance
ELUT
| |
|
ELUT's Source of Revenues |
During the corresponding time, Elutia Inc saw a revenue deteriorated by -6.61 % year on year, sequentially revenue fell by -13.71 %. While revenue at the Elutia Inc 's corporate clients
• List of ELUT Customers
|
|
|
for the same period Elutia Inc revnue deteriorated by -6.61 % year on year, sequentially revenue fell by -13.71 %.
• List of ELUT Customers
| |
| Ligand Pharmaceuticals Revenue Interest Obligation |
|
 54.98 % |
of total Revenue |
| Device Protection |
|
56.42 % |
of total Revenue |
| Women s Health |
|
48.1 % |
of total Revenue |
| Cardiovascular |
|
5.97 % |
of total Revenue |
|
Select the Relationship:
|
|
Select the Category:
|
|
Elutia Inc's Comment on Sales, Marketing and Customers
News about Elutia Inc Contracts |
Groundbreaking Study Confirms the Efficacy of Elutia s Antibiotic-Eluting BioEnvelope, EluPro, in Preventing Cardiac Device Infections Elutia Inc. a leader in the development of advanced medical devices, has recently unveiled a crucial publication that underscores the formidable effectiveness of its flagship product, the EluPro Antibiotic-Eluting BioEnvelope. This peer-reviewed study, epitomizing rigorous scientific scrutiny, provides robust evidence attesting to EluPro?s capacity to eradicate bacteria commonly associated with infections following the implantation of cardiac devices.The publication presents data derived from an established preclinical infection model, emphasizing the clinical significance an...
|
ELUT's vs. Customers, Data
(Revenue and Income for Trailing 12 Months, in Millions of $, except Employees)
| COMPANY NAME |
MARKET CAP |
REVENUES |
INCOME |
EMPLOYEES |
| Elutia Inc |
76.81 |
23.32 |
-39.89 |
- |
| SUBTOTAL |
0.00 |
0.00 |
0.00 |
- |
|
|
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.
Copyright © 2025 CSIMarket, Inc. All rights
reserved.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
